Get Live Data

The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Latest Share Chat

  2. Share Prices
  3. Reneuron Share Price
  4. Reneuron Share News
  5. UK earnings, trading statements calendar - next 7 days

Pin to quick picksReneuron Share News (RENE)

Reneuron Information
  • This share is currently suspended. It was suspended at a price of 3.275

Share Price Information for Reneuron (RENE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.275
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 3.275
RENE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK earnings, trading statements calendar - next 7 days

Thu, 18th May 2023 15:03

Friday 19 May 
IQE PLCFull Year Results
Knights Group Holdings PLCTrading Statement
Smiths Group PLCQ3 Results
Titon Holdings PLCHalf Year Results
Tharisa PLCHalf Year Results
Monday 22 May 
Big Yellow Group PLCFull Year Results
Chrysalis Investments LtdTrading Statement
Henderson European Focus Trust PLCHalf Year Results
Kainos Group PLCFull Year Results
Pershing Square Holdings LtdQ1 Results
Ryanair Holdings PLCFull Year Results
Schroder Oriental Income Fund LtdHalf Year Results
Wincanton PLCFull Year Results
Tuesday 23 May 
Assura PLCFull Year Results
Avon Protection PLCHalf Year Results
Benchmark Holdings PLCHalf Year Results
Bytes Technology Group PLCFull Year Results
Caledonian Trust PLCFull Year Results
Calnex Solutions PLCFull Year Results
Cranswick PLCFull Year Results
Engage XR Holdings PLCFull Year Results
FD Technologies PLCFull Year Results
Forterra PLCFull Year Results
Harworth Group PLCTrading Statement
Helical PLCFull Year Results
Hilton Food Group PLCTrading Statement
Ixico PLCHalf Year Results
JPMorgan China Growth & Income PLCHalf Year Results
Pebble Group PLCFull Year Results
Princess Private Equity Holding LtdQ1 Results
Residential Secure Income PLCHalf Year Results
RS Group PLCFull Year Results
Schroder AsiaPacific Fund PLCHalf Year Results
Seraphim Space Investment Trust PLCQ1 Results
SSP Group PLCHalf Year Results
Topps Tiles PLCHalf Year Results
Trellus Health PLCFull Year Results
Victorian Plumbing Group PLCHalf Year Results
Watkin Jones PLCHalf Year Results
Wednesday 24 May 
Aviva PLCTrading Statement
Bakkavor Group PLCTrading Statement
Bodycote PLCTrading Statement
C&C Group PLCFull Year Results
Close Brothers Group PLCTrading Statement
Ediston Property Investment Co PLCHalf Year Results
Empiric Student Property PLCTrading Statement
Esken LtdFull Year Results
Great Portland Estates PLCFull Year Results
Gym Group PLCTrading Statement
HICL Infrastructure PLCFull Year Results
Intertek Group PLCTrading Statement
Kier Group PLCTrading Statement
Kingfisher PLCQ1 Results
LondonMetric Property PLCFull Year Results
Majedie Investments PLCHalf Year Results
Marks & Spencer Group PLCFull Year Results
Mediclinic International PLCFull Year Results
Mortgage Advice Bureau Holdings PLCTrading Statement
N Brown Group PLCFull Year Results
Petershill Partners PLCTrading Statement
Purplebricks Group PLCTrading Statement
Regional REIT LtdTrading Statement
Severn Trent PLCFull Year Results
Sondrel Holdings PLCFull Year Results
SSE PLCFull Year Results
Tullow Oil PLCTrading Statement
Wynnstay Properties PLCFull Year Results
Zotefoams PLCTrading Statement
Thursday 25 May 
AJ Bell PLCHalf Year Results
Blackrock Frontiers Investment Trust PLCHalf Year Results
Caledonia Investments PLCFull Year Results
CT Private Equity Trust PLCQ1 Results
DWF Group PLCTrading Statement
Edinburgh Investment Trust PLCFull Year Results
Fevertree Drinks PLCTrading Statement
Headlam Group PLCTrading Statement
Henry Boot PLCTrading Statement
Hill & Smith PLCTrading Statement
Inspecs Group PLCTrading Statement
Intermediate Capital Group PLCFull Year Results
Jadestone Energy PLCFull Year Results
Johnson Mattey PLCFull Year Results
Pets At Home Group PLCFull Year Results
Pharos Energy PLCTrading Statement
Picton Property Income LtdFull Year Results
Qinetiq Group PLCFull Year Results
ReNeuron Group PLCFull Year Results
Renewi PLCFull Year Results
S&U PLCTrading Statement
Sabre Insurance Group PLCQ1 Results
Shires Income PLCFull Year Results
Tate & Lyle PLCFull Year Results
Triad Group PLCFull Year Results
United Utilities Group PLCFull Year Results
Vanquis Banking Group PLCTrading Statement
Workspace Group PLCFull Year Results
Young & Co's Brewery PLCFull Year Results
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
23 Oct 2019 09:32

ReNeuron Shares Jump As Lead Cell Line Shows Further Potential

ReNeuron Shares Jump As Lead Cell Line Shows Further Potential

Read more
2 Oct 2019 15:15

ReNeuron Reports Mixed Results For Retinitis Pigmentosa Trial

ReNeuron Reports Mixed Results For Retinitis Pigmentosa Trial

Read more
21 Aug 2019 11:49

ReNeuron boosts scientific advisory board with three appointments

(Sharecast News) - Cell-based therapeutics developer ReNeuron Group announced the appointment of professor Robert MacLaren, Dr Sally Temple and Dr José-Alain Sahel to its scientific advisory board on Wednesday.

Read more
14 Aug 2019 15:35

ReNeuron's New Cardiff University Venture Gets Research Grant

(Alliance News) - ReNeuron Group PLC on Wednesday said a new venture with Cardiff University has secured a UK government grant to research and develop new treatments for hard-to-target disorders a

Read more
14 Aug 2019 11:16

ReNeuron enters grant-funded partnership with University of Cardiff

(Sharecast News) - Cell-based therapeutics developer ReNeuron Group is partnering with the University of Cardiff under a new grant-funded collaboration utilising its exosome-based drug delivery technology platform, it announced on Wednesday.

Read more
16 Jul 2019 12:16

ReNeuron Secures Patents For Its Exosome Technology Platform

(Alliance News) - ReNeuron Group PLC on Tuesday said it has expanded its intellectual property estate via the grant of patents, covering its exosome technology platform.The cell-based said

Read more
11 Jul 2019 11:36

ReNeuron Annual Loss Narrows On Finance Income And Licence Fee

(Alliance News) - ReNeuron Group PLC on Thursday said its loss narrowed in its most recent financial year after it received an exclusivity fee and increased finance income.Shares in were at

Read more
14 Jun 2019 15:49

ReNeuron wins 'Breakthrough of the Year' at European Mediscience Awards

(Sharecast News) - Cell-based therapeutics developer ReNeuron Group has won the 'Breakthrough of the Year' award at the 2019 European Mediscience Awards, it announced on Friday.

Read more
8 May 2019 11:19

ReNeuron Expects Annual Results In Line With Views After Progress

LONDON (Alliance News) - ReNeuron Group PLC on Wednesday said it expects its annual results to be in line with the board's expectations as it made progress on several clinical cell-based also

Read more
8 May 2019 08:53

ReNeuron advances blindness and stroke therapy candidates

(Sharecast News) - Therapeutics outfit ReNeuron continued to trade in line with expectations throughout its recently wrapped up trading year, advancing both its human retinal progenitor cell therapy candidate and its CTX cell therapy candidate.

Read more
26 Apr 2019 12:09

ReNeuron upbeat on early data from retinitis pigmentosa trials

(Sharecast News) - Cell-based therapeutics developer ReNeuron Group announced updated positive preliminary data in its ongoing phase 1 and 2a clinical trial of its human retinal progenitor cell (hRPC) therapy candidate in the blindness-causing disease, retinitis pigmentosa (RP), on Friday.

Read more
26 Apr 2019 09:58

ReNeuron Reports Positive Test Results For Blindness Treatment Therapy

LONDON (Alliance News) - ReNeuron Group PLC on Friday reported positive trial results for its human retinal progenitor cell therapy candidate for treating blindness-causing disease retinitis in up

Read more
11 Apr 2019 18:24

DIRECTOR DEALINGS: ReNeuron Chair And Other Board Members Buy Shares

LONDON (Alliance News) - ReNeuron Group PLC said a number of directors purchased shares on Thursday, including Non-Executive Chair John Berriman who bought 80,000 shares at 225 pence Thursday, in

Read more
9 Apr 2019 10:55

ReNeuron Signs Licence Deal For CTX, hRPC Cell Programmes In China

LONDON (Alliance News) - ReNeuron Group PLC on Tuesday said it has signed an exclusive licence agreement for the development, manufacture and commercialisation of its CTX and hRPC cell therapy in

Read more
4 Apr 2019 14:19

ReNeuron upbeat on progress in hRPC study

(Sharecast News) - Cell-based therapeutics developer ReNeuron Group updated the market on progress with its ongoing phase 1 and 2 clinical trial in the US of its 'hRPC' cell therapy candidate in the blindness-causing disease retinitis pigmentosa (RP) on Thursday, confirming that the positive efficacy seen and previously announced had, to date, been sustained in the first patient cohort in the phase 2 part of the study.

Read more
12345678910

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.